Does Pregabalin Affect Renal Functions and Plasma Electrolytes?

RAVİYE ÖZEN KOCA; Ahmet Can Günay; Merve AKGÜL GÜNAY; Z IŞIK SOLAK GÖRMÜŞ; FAİK ÖZDENGÜL

doi:10.56752/Mevmedsci.2024.63

RAVİYE ÖZEN KOCA,Ahmet Can Günay,Merve AKGÜL GÜNAY,Z IŞIK SOLAK GÖRMÜŞ,FAİK ÖZDENGÜL

RAVİYE ÖZEN KOCA: NECMETTİN ERBAKAN ÜNİVERSİTESİ
Ahmet Can Günay: Necmettin Erbakan Üniversitesi Tıp Fakültesi
Merve AKGÜL GÜNAY: Karamanoğlu Mehmetbey Üniversitesi Tıp Fakültesi
Z IŞIK SOLAK GÖRMÜŞ: NECMETTİN ERBAKAN ÜNİVERSİTESİ
FAİK ÖZDENGÜL: NECMETTİN ERBAKAN ÜNİVERSİTESİ

Year : 2024
Vol : 4
Issue : 2
Page : 74-80

DOI : https://doi.org/10.56752/Mevmedsci.2024.63

Aim: It is known that the half-life of pregabalin increases with age. This may be related to the decline in kidney function with age. In this study, it was aimed to investigate the neurotoxicity and renal toxicity that pregabalin may cause.
Materials and Methods: 100 patients followed up in the Department of Neurology between 2019-2020 were included for the study.It was planned to scan the hospital files of the adult patient group using pregabalin. The data obtained as a result of possible changes in serum electrolyte levels and kidney functions of patients with pregabalin indication were evaluated. Peripheral blood urea, uric acid, creatinine, serum electrolyte levels of the patients were determined and glomerular filtration rate (GFR) was analyzed twice, in six months for possible changes in kidney functions.
Results: Arithmetic mean values and changes were examined in patients who were measured twice in a six-month period. The effect of pregabalin use on urea and uric acid values, which are markers of renal function, was found to be statistically significant (p<0.05). There was no statistically significant effect on GFR, creatinine, Na+, Cl–, K+, Ca+2, Mg+2 and P+3 parameters (p>0.05).
Conclusion: This study may be useful to investigate the effects of pregabalin on other organs. The data obtained may contribute to the provision of information that may be useful to drug research and development institutions and to increase drug safety.

Cite this Article As : Gunay AC, Ozen Koca R, Akgul Gunay M, Ozdengul F, Solak Gormus ZI. Does Pregabalin Affect Renal Functions and Plasma Electrolytes? Mev Med Sci. 2024; 4(2): 74-80

Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.

Mevlana Tıp Bilimleri
2024, Vol4, Issue2
E-ISSN: 2757-976X

Received : 13.02.2024, Accepted : 06.05.2024 , Published Online : 07.08.2024

References

1. Yamanoglu T. 2015. Chronopharmacology of the Interaction Between Pregabalin and Morphine (PhD Thesis), Gazi University, Ankara.
2. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45 Suppl 6:13-8. doi: 10.1111/j.0013-9580.2004.455003.x.
3. Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009; 8;(3):CD007076. doi: 10.1002/14651858.CD007076.pub2.
4. Dworkin RH, Kirkpatrick P. Pregabalin. Nat Rev Drug Discov. 2005 Jun;4(6):455-6. doi: 10.1038/nrd1756.
5. Kavoussi R. Pregabalin: From molecule to medicine. Eur Neuropsychopharmacol. 2006 Jul;16 Suppl 2:S128-33. doi: 10.1016/j.euroneuro.2006.04.005. Epub 2006 Jun 9.
6. Taylor DM, Barnes TR, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. 13th edition. Hoboken, NJ : Wiley, 2019.
7. Sinha N. Pregabalin. The Essence of Analgesia and Analgesics. Anticonvulsant-Type Analgesics. Sinatra RS, Jahr JS, Watkins-Pitchford JM ed.2010; 72 (6).
8. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006 Mar;61(3):246-55. doi: 10.1111/j.1365-2125.2005.02529.x.
9. Naidoo S, Meyers AM. Drugs and the kidney. S Afr Med J. 2015 Mar 7;105(4):2683. doi: 10.7196/samj.9537.
10. Jung YJ, Lee DY, Kim HW, et al. A Case Report of Syndrome of Inappropriate Antidiuretic Hormone Induced by Pregabalin. Electrolyte Blood Press. 2016 Dec;14(2):31-34. doi: 10.5049/EBP.2016.14.2.31.
11. Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J. 2004 Jan-Feb;34(1-2):50-7. doi: 10.1111/j.1444-0903.2004.t01-6-.x.
12. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006 Jun 8;354(23):2473-83. doi: 10.1056/NEJMra054415. PMID: 16760447.
13. Fenton A, Montgomery E, Nightingale P, et al. Glomerular filtration rate: new age- and gender- specific reference ranges and thresholds for living kidney donation. BMC Nephrol. 2018 Nov 22;19(1):336. doi: 10.1186/s12882-018-1126-8.
14. Wang H, Ran J, Jiang T. Urea. Subcell Biochem. 2014;73:7-29. doi: 10.1007/978-94-017-9343-8_2.
15. Matovinović MS. 1. Pathophysiology and Classification of Kidney Diseases. EJIFCC. 2009 Apr 20;20(1):2-11.
16. Yang HC, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Discov Today Dis Models. 2010;7(1-2):13-19. doi: 10.1016/j.ddmod.2010.08.002.
17. Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001 Nov;24(6):691-7. doi: 10.1291/hypres.24.691.
18. Lee DW, Lee HJ, Kim HJ, et al. Two cases of pregabalin neurotoxicity in chronic kidney disease patients. NDT Plus. 2011 Apr;4(2):138. doi: 10.1093/ndtplus/sfq219.
19. Traynor J, Mactier R, Geddes CC, et al. How to measure renal function in clinical practice. BMJ. 2006 Oct 7;333(7571):733-7. doi: 10.1136/bmj.38975.390370.7C.
20. Shrimanker I, Bhattarai S. Electrolytes. 2022 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.
21. Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers. J Clin Pharmacol. 2010 Aug;50(8):941-50. doi: 10.1177/0091270009352087.